PROCESSA PHARMACEUTICALS, INC. (OTCMKTS: PCSA) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.01 Notice of delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On December 5, 2018 Processa Pharmaceuticals, Inc. received written notice that the Company’s common stock will commence trading on OTCQB, under its existing symbol “PCSA at the opening on December 6, 2018. The Company had previously traded on OTC Pink Marketplace. A copy of the press release is attached as Exhibit 99.1

The information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 8.01 Other Events.

The disclosures set forth in Item 3.01 above are incorporated into this reporting item by reference.

Processa Pharmaceuticals, Inc. Exhibit
EX-99.1 2 ex99-1.htm   FOR IMMEDIATE RELEASE For More Information:   Patrick Lin   [email protected]   925-683-3218   PROCESSA PHARMACEUTICALS ANNOUNCES UP-LISTING TO OTCQB MARKET   December 6,…
To view the full exhibit click here